multiple myeloma and plasma cell neoplasm

Showing 26 - 50 of 286

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Buffalo (biological, drug, procedure)

Completed
  • Chronic Myeloproliferative Disorders
  • +7 more
  • anti-thymocyte globulin
  • +11 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jan 29, 2020

Multiple Myeloma and Plasma Cell Tumor Trial in Philadelphia (bortezomib, hydroxychloroquine)

Completed
  • Multiple Myeloma and Plasma Cell Neoplasm
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Feb 5, 2020

Multiple Myeloma and Plasma Cell Tumor Trial in Rochester (dexamethasone, lenalidomide)

Completed
  • Multiple Myeloma and Plasma Cell Neoplasm
  • Rochester, Minnesota
    Mayo Clinic
Jan 9, 2020

Breast Cancer, Chronic Myeloproliferative Disorders, Colorectal Cancer Trial in Pittsburgh, Madison (doxorubicin HCl, motexafin

Completed
  • Breast Cancer
  • +11 more
  • doxorubicin hydrochloride
  • motexafin gadolinium
  • Pittsburgh, Pennsylvania
  • +1 more
Dec 12, 2019

GVHD, Leukemia, Lymphoma Trial in Buffalo (biological, drug, procedure, radiation)

Completed
  • Graft Versus Host Disease
  • +4 more
  • anti-thymocyte globulin
  • +8 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Nov 25, 2019

Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in United States (biological, drug, procedure, radiation)

Withdrawn
  • Leukemia
  • +4 more
  • alemtuzumab
  • +6 more
  • La Jolla, California
  • +23 more
Nov 25, 2019

Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in Baltimore (biological, drug, procedure)

Completed
  • Leukemia
  • +3 more
  • daclizumab
  • +4 more
  • Baltimore, Maryland
    Marlene & Stewart Greenebaum Cancer Center, University of Maryla
Oct 31, 2019

Infection, Multiple Myeloma and Plasma Cell Tumor Trial in Baltimore, Philadelphia (biological, drug, procedure)

Completed
  • Infection
  • Multiple Myeloma and Plasma Cell Neoplasm
  • filgrastim
  • +8 more
  • Baltimore, Maryland
  • +1 more
Oct 31, 2019

Multiple Myeloma and Plasma Cell Tumor Trial in Baltimore (carmustine, cisplatin, cyclophosphamide)

Completed
  • Multiple Myeloma and Plasma Cell Neoplasm
  • Baltimore, Maryland
    Marlene & Stewart Greenebaum Cancer Center, University of Maryla
Oct 15, 2019

Anemia, GVHD, Leukemia Trial in Baltimore (biological, drug, procedure, radiation)

Completed
  • Anemia
  • +5 more
  • anti-thymocyte globulin
  • +6 more
  • Baltimore, Maryland
    Marlene & Stewart Greenebaum Cancer Center, University of Maryla
Oct 15, 2019

Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in Baltimore (biological, drug, procedure, radiation)

Completed
  • Leukemia
  • +3 more
  • anti-thymocyte globulin
  • +5 more
  • Baltimore, Maryland
    Marlene & Stewart Greenebaum Cancer Center, University of Maryla
Oct 15, 2019

Multiple Myeloma and Plasma Cell Tumor Trial in Baltimore (carmustine, cisplatin, cyclophosphamide)

Completed
  • Multiple Myeloma and Plasma Cell Neoplasm
  • Baltimore, Maryland
    Marlene & Stewart Greenebaum Cancer Center, University of Maryla
Oct 15, 2019

Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in Baltimore (filgrastim, therapeutic allogeneic lymphocytes,

Completed
  • Leukemia
  • +3 more
  • filgrastim
  • +3 more
  • Baltimore, Maryland
    Marlene & Stewart Greenebaum Cancer Center, University of Maryla
Oct 15, 2019

Multiple Myeloma and Plasma Cell Tumor Trial in Baltimore, New York (oblimersen sodium, dexamethasone, thalidomide)

Completed
  • Multiple Myeloma and Plasma Cell Neoplasm
  • oblimersen sodium
  • +2 more
  • Baltimore, Maryland
  • +1 more
Oct 15, 2019

Multiple Myeloma and Plasma Cell Tumor Trial in Scottsdale, Jacksonville, Rochester (lenalidomide, melphalan, prednisone)

Completed
  • Multiple Myeloma and Plasma Cell Neoplasm
  • Scottsdale, Arizona
  • +2 more
Sep 18, 2019

Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in United States (biological, drug, procedure, radiation)

Completed
  • Leukemia
  • +4 more
  • therapeutic allogeneic lymphocytes
  • +6 more
  • Denver, Colorado
  • +13 more
Sep 13, 2019

Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in Iowa City, Rochester (RAD001, Sorafenib)

Completed
  • Lymphoma
  • Multiple Myeloma and Plasma Cell Neoplasm
  • Iowa City, Iowa
  • +1 more
Aug 9, 2019

Multiple Myeloma and Plasma Cell Tumor Trial in Rochester (dexamethasone, sorafenib tosylate, Lenalidomide)

Terminated
  • Multiple Myeloma and Plasma Cell Neoplasm
  • Rochester, Minnesota
    Mayo Clinic
Aug 12, 2019

Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in Warsaw (autologous lymphoma cell lysate-pulsed autologous dendritic

Completed
  • Lymphoma
  • Multiple Myeloma and Plasma Cell Neoplasm
  • autologous lymphoma cell lysate-pulsed autologous dendritic cell vaccine
  • +2 more
  • Warsaw, Poland
    Maria Sklodowska-Curie Memorial Cancer Center and Institute of O
Aug 14, 2019

Multiple Myeloma and Plasma Cell Tumor Trial in Phoenix, Duarte (biological, drug, procedure)

Completed
  • Multiple Myeloma and Plasma Cell Neoplasm
  • filgrastim
  • +7 more
  • Phoenix, Arizona
  • +1 more
Jun 24, 2019

Leukemia, Lymphoma, Mature T-cell and Nk-cell Tumors Trial in Switzerland (bortezomib, nelfinavir mesylate)

Completed
  • Leukemia
  • +3 more
  • Bern, Switzerland
  • +3 more
May 14, 2019

Chronic Myeloproliferative Disorders, GVHD, Leukemia Trial in Detroit (biological, drug, other, procedure)

Terminated
  • Chronic Myeloproliferative Disorders
  • +7 more
  • anti-thymocyte globulin
  • +7 more
  • Detroit, Michigan
    Karmanos Cancer Institute
Mar 13, 2019

Multiple Myeloma and Plasma Cell Tumor Trial in Boston, Milwaukee (therapeutic allogeneic lymphocytes)

Completed
  • Multiple Myeloma and Plasma Cell Neoplasm
  • therapeutic allogeneic lymphocytes
  • Boston, Massachusetts
  • +1 more
Dec 30, 2018

Multiple Myeloma and Plasma Cell Tumor Trial in United States (biological, drug, procedure)

Completed
  • Multiple Myeloma and Plasma Cell Neoplasm
  • sargramostim
  • +5 more
  • Jacksonville, Florida
  • +11 more
Dec 30, 2018

Multiple Myeloma and Plasma Cell Tumor Trial in Baltimore (MILs, Melphalan, PCV13)

Completed
  • Multiple Myeloma and Plasma Cell Neoplasm
  • MILs
  • +2 more
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Nov 29, 2018